key: cord-0877069-yncr6mll
authors: Wang, Mingke; Peng, Jianhui; Hui, Jufen; Hou, Dengyong; Li, Weipeng; Yang, Jishun
title: Hydrogen therapy as an effective and novel adjuvant treatment against COVID-19
date: 2020-11-05
journal: QJM
DOI: 10.1093/qjmed/hcaa301
sha: f03da4ad6ec9c141f8bec68283461eaec7152820
doc_id: 877069
cord_uid: yncr6mll

nan

Dear Editor,

We read with great interest the recent article by Wang et al 1 , which showed that 45 minitues hydrogen gas (XEN) inhalation once attenuated airway inflammation in asthma and COPD patients by mainly inhibiting the pro-inflammatory cytokines of MCP-1, IL-4 and IL-6. High IL-6 level had also been found closely correlated with the incidence of Hydrogen (H 2 ) is colorless, odorless, and the lightest of gas molecules in the universe.

Since the first reported hydrogen therapy in a skin squamous carcinoma mouse model, studies in the past ten years have indicated that H 2 has therapeutic effects in diverse animal models and human disease, including metabolic syndrome, organ injury(respiratory system, nervous system, reproductive system, etc.), radiation damage and cancer, from acute illness to chronic illness 7, 8 . We hypothesize that hydrogen therapy may be as an effective and novel adjuvant treatment against COVID-19, and exhibit beneficial potential to prevent COVID-19-associated cytokine storm and multiple organ https://mc.manuscriptcentral.com/qjm damage through following multiple mechanisms 8 In conclusion, with the effects on selective anti-oxidation, anti-apoptosis, anti-inflammation, gene expression alterations, and as a gaseous signal modulator 8 , hydrogen therapy may be a novel, promising and effective adjuvant treatment against COVID-19. Although additional experiments and clinical studies are required to confirm this hypothesis, we hope that hydrogen therapy would provide an emerging and good option for the currently limited prevention and treatment strategy of COVID-19.

https://mc.manuscriptcentral.com/qjm Conflict of interest：None declared.

Hydrogen gas (XEN) inhalation ameliorates airway inflammation in asthma and COPD patients

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically

level in critically ill COVID-19 patients

World Health Organization. Weekly epidemiological update coronavirus disease 2019 (COVID-19)

Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm

Vitamin D can prevent COVID-19 infection-induced multiple organ damage

Hyperbaric hydrogen therapy: a possible treatment for cancer

Molecular hydrogen: a preventive and therapeutic medical gas for various diseases

Hydrogen-rich water attenuates oxidative stress in rats with traumatic brain injury via Nrf2 pathway

Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Hydrogen-rich saline protects immunocytes from radiation-induced apoptosis

Effects of hydrogen-rich saline on early acute kidney injury in severely burned rats by suppressing oxidative stress induced apoptosis and inflammation

Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19

COVI-19 or SARS-CoV-2): anti-inflammatory strategies